Table 3.
Liver histopathological scoring of healthy and NASH rats receiving either CDDP or vehicle.
| Disease | Drug | Total | Lipid accumulation | Necrosis | Apoptosis | Inflammation | Fibrosis | Biliary hyperplasia |
|---|---|---|---|---|---|---|---|---|
| Control | Naïve | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CDDP | 0 | 0.17 ± 0.41 | 0 | 0 | 0 | 0 | 0 | |
| NASH | Naïve | 2.33 ± 0.52 | 3.50 ± 0.55 | 0.83 ± 0.41 | 0.33 ± 0.52 | 1.67 ± 0.52 | 0.33 ± 0.52 | 1.50 ± 1.05 |
| CDDP | 1.80 ± 0.45 | 2.80 ± 0.45 | 0.40 ± 0.55 | 0.80 ± 0.45 | 1.60 ± 0.55 | 0 | 1.40 ± 0.55 | |
| Two-way ANOVA | Diet | ∗∗∗∗ | ∗∗∗∗ | ∗∗∗ | ∗∗∗ | ∗∗∗∗ | ns | ∗∗∗∗ |
| Drug | ns | ns | ns | ns | ns | ns | ns |
Mean scores represent n = 6 rats/group with the total being the average of the sum of all scores.
Means were compared by two-way analysis of variance where P < 0.05 (∗), <0.01 (∗∗), <0.001 (∗∗∗), <0.0001 (∗∗∗∗).